Form 4: Macrogenics CEO Scott Koenig Transfers Shares via Gift
SEC Form 4 Filing
CEO Scott Koenig reports gifting shares of Macrogenics stock, with a corresponding acquisition by an irrevocable trust.
Summary
- On October 7, 2024, Scott Koenig, the President and CEO of Macrogenics Inc., reported a transaction involving the company's common stock.
- Koenig gifted 53,265 shares of common stock.
- Concurrently, The Koenig 2024 Irrevocable Trust acquired 53,265 shares.
- Following these transactions, Koenig directly owns 0 shares and The Koenig 2024 Irrevocable Trust indirectly owns 427,480 shares.
- The transfer is reported as a gift and may be exempt under Rule 16a-13 as a change in the form of beneficial ownership.
- Koenig disclaims beneficial ownership of shares held by the irrevocable trust except to the extent of his pecuniary interest therein.
Sentiment
Score: 7
Explanation: The document reflects a neutral transaction (gifting of shares) with no apparent negative implications for the company. The sentiment is therefore moderately positive.
Industry Context
This filing reflects routine transactions related to executive compensation and estate planning, common in publicly traded companies.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders, as it is a personal financial matter for the CEO and does not affect the company's operations or financial position.
Key Dates
| Date | Description |
|---|---|
| 10/07/2024 | Date of stock gift and acquisition by the irrevocable trust |
| 10/09/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.